Nuvance Health Opens COVID-19 Collection Sites in Dutchess and Ulster Counties for Pre-Screened People

Dutchess County Executive Marc Molinaro has announced Nuvance Health will be operating a drive-through collection site at the Intermodal Center at Dutchess Stadium. Please see the following release from Nuvance Health:

Nuvance Health Opens COVID-19 Collection Sites in Dutchess
and Ulster Counties for Pre-Screened People

Appointment-only sites to collect samples for testing from people with physician’s order

FISHKILL, NY, and KINGSTON, NY— March 22, 2020 — Nuvance Health, in cooperation with Dutchess and Ulster counties, will open two COVID-19 (coronavirus) drive-through collection sites on Monday, March 23.

The sites are the Intermodal Center at Dutchess Stadium on Route 9D in Fishkill and Tech City at 300 Enterprise Drive in Kingston. Enterprise Drive is easily accessible from either Route 209 or Route 9W via Boice Lane. The Dutchess Stadium site will open at noon and Tech City at 8:30 a.m.

These sites are used to collect samples from people who are experiencing symptoms of COVID-19. The samples will be sent offsite for testing. A person must have a physician’s order before entering these locations.

“We established these collection sites to provide a safe alternate location for symptomatic patients to be screened for COVID-19,” said Sandra Iberger, Vice President of Ambulatory Services at Nuvance Health. “Currently, patients have been seeking testing via the Emergency Department and physician offices, which are not the appropriate setting for testing.”

Both collection sites will be available for pre-screened people suspected of having COVID-19 to give a specimen sample for a test. This is not a testing site. Testing is done offsite and results are not immediately available. The collection site is ONLY for people who meet ALL of the following criteria:

• You called your doctor’s office and had a consultation.
• Based on your symptoms and other information you provided, your doctor determined you meet criteria for COVID-19 testing and ordered a test for you.
• You have a scheduled appointment at the collection site. Your doctor will give you the phone number to call to schedule an appointment at the collection site.

“We are grateful for our community partner, Nuvance Health, for expediting the process to expand testing for COVID-19 in Dutchess County, and we are thrilled to utilize the intermodal center at Dutchess Stadium in as a site for county residents,” Dutchess County Executive Marc Molinaro said. “The ability to test residents will provide us a more accurate picture of the spread of the virus throughout our community, enabling Dutchess County Government to deploy resources even more effectively to safeguard even more residents’ health.”

“Adding this mobile testing site will save lives. It will provide a significant surge in testing capacity, which will enable us to better treat those affected and slow the spread of COVID-19,” Ulster County Executive Pat Ryan said. “I want to thank Nuvance Health for stepping up during this critical moment for our community. Our entire team will continue to work around the clock to keep every Ulster County resident safe and healthy."

Healthcare providers from Nuvance Health and law enforcement will work at the two sites. Three additional providers from Ellenville Hospital will assist at the Tech City site.

At both locations, a trained provider will use a swab to collect a nasal sample. That sample will then be sent to a lab for testing. This is not a blood test. It may take up to six days to get the test results back. Your doctor will notify you of the results. Only call your doctor if you have not heard back in seven days.

Hours of operation at both sites are Monday through Saturday, 8:30 a.m. to 3:30 p.m., and are subject to change.

For more information including the criteria and the process for scheduling an appointment at the drive-through sites, visit Nuvancehealth.org/NYCollectionSites

Also visit http://NuvanceHealth.org/coronavirus for other information on COVID-19.